Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

Authors: Gesine F C Weckmann, Sylvia Stracke, Annekathrin Haase, Jacob Spallek, Fabian Ludwig, Aniela Angelow, Jetske M Emmelkamp, Maria Mahner, Jean-François Chenot

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is age-dependent and has a high prevalence in the general population. Most patients are managed in ambulatory care. This systematic review provides an updated overview of quality and content of international clinical practice guidelines for diagnosis and management of non-dialysis CKD relevant to patients in ambulatory care.

Methods

We identified guidelines published from 2012-to March 2018 in guideline portals, databases and by manual search. Methodological quality was assessed with the Appraisal of Guidelines for Research and Evaluation II instrument. Recommendations were extracted and evaluated.

Results

Eight hundred fifty-two publications were identified, 9 of which were eligible guidelines. Methodological quality ranged from 34 to 77%, with domains “scope and purpose” and “clarity of presentation” attaining highest and “applicability” lowest scores. Guidelines were similar in recommendations on CKD definition, screening of patients with diabetes and hypertension, blood pressure targets and referral of patients with progressive or stage G4 CKD. Definition of high risk groups and recommended tests in newly diagnosed CKD varied.

Conclusions

Guidelines quality ranged from moderate to high. Guidelines generally agreed on management of patients with high risk or advanced CKD, but varied in regarding the range of recommended measurements, the need for referrals to nephrology, monitoring intervals and comprehensiveness. More research is needed on efficient management of patients with low risk of CKD progression to end stage renal disease.
Appendix
Available only for authorised users
Literature
3.
go back to reference Morgan T. Chronic kidney disease (stages 3–5) prevalence estimates using data from the Neoerica study (2007). England: Association of Public Health Observatories; 2009. Morgan T. Chronic kidney disease (stages 3–5) prevalence estimates using data from the Neoerica study (2007). England: Association of Public Health Observatories; 2009.
4.
go back to reference Kearns B. Chronic kidney disease prevalence modelling briefing document. 2009. Kearns B. Chronic kidney disease prevalence modelling briefing document. 2009.
9.
go back to reference KDIGO. Clinical practice guideline for lipid management in chronic kidney disease. New York, NY: Nature Publ. Group; 2013. KDIGO. Clinical practice guideline for lipid management in chronic kidney disease. New York, NY: Nature Publ. Group; 2013.
10.
go back to reference McIntyre NJ, Fluck R, McIntyre C, Taal M. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract. 2012;62:32.CrossRef McIntyre NJ, Fluck R, McIntyre C, Taal M. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract. 2012;62:32.CrossRef
16.
go back to reference Navaneethan SD, Kandula P, Jeevanantham V, Nally JV, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010;73:260–7.CrossRef Navaneethan SD, Kandula P, Jeevanantham V, Nally JV, Liebman SE. Referral patterns of primary care physicians for chronic kidney disease in general population and geriatric patients. Clin Nephrol. 2010;73:260–7.CrossRef
20.
go back to reference Haute Autorité de Santé: Guide parcours de soins maladie rénale chronique de l'adulte; 2012. Accessed 20 Mar 2018. Haute Autorité de Santé: Guide parcours de soins maladie rénale chronique de l'adulte; 2012. Accessed 20 Mar 2018.
24.
go back to reference Chi C, Moore M, Murphy TV, Patel PR, Pilishvili T, Strikas RA. Guidelines for vaccinating dialysis patients and patients with chronic kidney disease: Summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: U.S. Dept. of Health & Human Services, Centers for Disease Control and Prevention (CDC); 2012. Chi C, Moore M, Murphy TV, Patel PR, Pilishvili T, Strikas RA. Guidelines for vaccinating dialysis patients and patients with chronic kidney disease: Summarized from recommendations of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: U.S. Dept. of Health & Human Services, Centers for Disease Control and Prevention (CDC); 2012.
25.
go back to reference Andrassy KM. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;84:622–3.CrossRef Andrassy KM. KDIGO 2012 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013;84:622–3.CrossRef
27.
go back to reference KDIGO. Clinical practice guideline for anemia in chronic kidney disease. New York, NY: Nature Publishing Group; 2012. KDIGO. Clinical practice guideline for anemia in chronic kidney disease. New York, NY: Nature Publishing Group; 2012.
28.
go back to reference National Institute for Health and Clinical Excellence (Great Britain). Chronic kidney disease: Early identification and management of chronic kidney disease in adults in primary and secondary care. London: NICE; 2015. National Institute for Health and Clinical Excellence (Great Britain). Chronic kidney disease: Early identification and management of chronic kidney disease in adults in primary and secondary care. London: NICE; 2015.
29.
go back to reference NICE - National Institute of Health and Care Excellence. Chronic kidney disease: managing anaemia: NICE guideline; 2015. NICE - National Institute of Health and Care Excellence. Chronic kidney disease: managing anaemia: NICE guideline; 2015.
34.
go back to reference Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14:1–184. https://doi.org/10.3310/hta14210.CrossRefPubMed Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14:1–184. https://​doi.​org/​10.​3310/​hta14210.CrossRefPubMed
37.
go back to reference World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. 2011. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. 2011.
Metadata
Title
Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines
Authors
Gesine F C Weckmann
Sylvia Stracke
Annekathrin Haase
Jacob Spallek
Fabian Ludwig
Aniela Angelow
Jetske M Emmelkamp
Maria Mahner
Jean-François Chenot
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1048-5

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.